• About Us
    • Contact Us
    • Login
    • ObGFirst
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • COVID-19
About Us Contact Us Login ObGFirst
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • COVID-19
Grand Rounds

Can Cervical Pessaries Prevent Preterm Birth?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE: 

  • Successful strategies to prevent preterm birth in women with threatened preterm birth and short cervix are not currently available  
  • Pratcorona et al. (AJOG, 2018) assessed whether cervical pessaries can help prevent spontaneous preterm birth in women at high risk following an episode of threatened preterm birth and cervical shortening

METHODS: 

  • Prospective open randomized controlled trial (RCT) 
  • Participants 
    • Singleton pregnancies between 24w0d and 33w6d gestation  
    • Arrested preterm labor episode 
      • Regular uterine contractions, with at least 2 painful contractions in 10 minutes averaged over 30 minutes 
      • No contractins 6 to 12 hours after tocolytics stopped  
    • Short cervix  
      • ≤25 mm between 24w0d–29w6d  
      • ≤15 mm between 30w0d–33w6d  
  • Routine management of threatened labor 
    • Hospitalization | Tocolytics (atosiban) | Corticosteroids | Antibiotics if needed 
  • Patients were randomized to receive 
    • Cervical pressary (placement confirmed by TV ultrasound)  
    • Routine management  
  • Primary outcome: Spontaneous preterm birth rate <34 weeks 
  • Secondary outcomes: 
    • Spontaneous preterm birth <28 and 37 weeks | PPROM | Neonatal morbidity and mortality outcomes | Maternal adverse events

RESULTS: 

  • 357 pregnant women were involved in the study 
    • 179 pessary | 178 no treatment  
  • There was no significant difference between the pessary and routine management groups for spontaneous preterm birth rate <34 weeks 
    • 10.7% in the pessary group vs 13.7% in the control group  
      • Relative risk (RR) 0.78; 95% Cl, 0.45-1.3) 
  • Spontaneous preterm birth <37 weeks occurred less frequently in the pessary group 
    •  14.7% in the pessary group vs 25.1% in the control group  
    • RR 0.58; 95% CI, 0.38-0.90 (P = .01) 
  • PPROM was significantly lower in pessary group 
    • 2.3% in the pessary group vs 8.0% in the control group  
    • RR 0.28; 95% CI, 0.09-0.84 (P = .01) 
  • Readmission for new threatened preterm labor episodes ≥1 was significantly reduced in the pessary group  
    • 4.5% in the pessary group vs 20.0% in the control group  
    • RR 0.23; 95% CI, 0.11-0.47 (P < .0001) 
  • There was no case of pessary withdrawal  
    • Some patients had moderate, white, nonodorous discharge  
    • 19.8% did perceive the presence of the pessary  
    • No difference in bleeding  
    • While there was pain reported on removal, patients with pessary would recommend to others 
  • There was no reduction in neonatal morbidity 
    • Study underpowered to assess most neonatal endpoints

CONCLUSION: 

  • Pessary use did not lower spontaneous preterm birth rate <34 weeks in women with a short cervix and threatened preterm labor episode 
  • However, pessary use did significantly reduce PPROM and spontaneous preterm birth rate in the late preterm period  
  • Larger trials may be needed to demonstrate neonatal benefit  
  • Authors conclude  

…the cervical pessary could be considered an affordable, safe, and reliable tool for reducing the risk of late spontaneous preterm birth in singleton pregnancies of women with short cervical length remaining after a threatened preterm labor, a high-risk population in which no intervention has proven efficacious to date.

Learn More – Primary Sources: 

Cervical pessary to reduce preterm birth <34 weeks of gestation after an episode of preterm labor and a short cervix: a randomized controlled trial

image_pdfFavoriteLoadingFavorite

< Previous
All Grand Rounds Posts
Next >

Related ObG Topics:

PoPPS Study: Does Pessary Use In Women with a Short Cervical Length Prevent Preterm Birth?
Short Cervix and Risk for Preterm Birth: Do Pessaries Work? 
SMFM Statement: Choice of Progestogen for Preterm Birth Prevention

Sections

  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • COVID-19

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site